And if taken for weight loss, the drug will likely be taken for life
Prescription instructions for Mounjaro or Zepbound apply only to their regulated formulations and delivery systems
The Drug Enforcement Administration (DEA) considers the medication to be highly addictive and even classifies it as a Schedule II controlled substance
*Correspondence: Antonio Di Sabatino, [email protected] This article was submitted to Gastroenterology, a section of the journal Frontiers in Medicine Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
WELCOMEHOME at checkout GLOW (GHK-CU, BPC-157 & TB-500) 70MG Research-Grade Reference Material GLOW (GHK-CU, BPC-157 & TB-500) 70MG is supplied as a lyophilized powder for in-vitro laboratory research use only
Clinical Trial Results Phase 2 trial (published 2023): Patients lost an average of ~25% of their body weight at 48 weeks